Stempoint Capital LP — 13F Holdings

2026 Q3  ·  130 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, STEMPOINT CAPITAL LP maintained a portfolio of 130 distinct positions. The most significant new addition was ADAPTIVE BIOTECHNOLOGIES COR, now representing 2.39% of the total fund value. They heavily accumulated shares in ERASCA INC, increasing the position by 1030.3%. The fund also reduced its exposure to REVOLUTION MEDICINES INC by 93.7%.
Position History hover any row below to update
Loading…
STEMPOINT CAPITAL LP New York, NY Hedge Fund AUM $558M
PCA Score Concentration Risk
Risk ENB
Total Positions
130
Quarter
2026 Q3
Top Holding
SRRK (5.9%)
Top 10 Concentration
39.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 130

STEMPOINT CAPITAL LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
SRRK
SCHOLAR ROCK HL...
Healthcare 5.95% 2.27% #1 11
Prev: #12
7.4
—
449,808 188.1%
P
S
688,954 $33,290,257 2024 Q4 13F Filing 2026-09-30 2026-11-16
ERAS
ERASCA INC
Healthcare 5.92% 4.94% #2 2
Prev: #4
6.4
—
694,681 44.4%
P
S
2,260,594 $33,140,308 2026 Q1 13F Filing 2026-09-30 2026-11-16
ABVX
ABIVAX SA
Healthcare 4.94% 6.51% #3 1
Prev: #2
3.5
—
-4,259 -1.5%
P
S
279,398 $27,665,990 2025 Q2 13F Filing 2026-09-30 2026-11-16
TNGX
TANGO THERAPEUT...
Healthcare 4.41% 6.59% #4 3
Prev: #1
2.8
—
-233,674 -19.1%
P
S
989,345 $24,684,158 2025 Q2 13F Filing 2026-09-30 2026-11-16
ROIV
ROIVANT SCIENCE...
Healthcare 4.19% 2.12% #5 11
Prev: #16
5.2
—
293,065 84.1%
P
S
641,473 $23,458,668 2023 Q4 13F Filing 2026-09-30 2026-11-16
TRAX
FIRST TRACKS BI...
Healthcare 4.12% 2.16% #6 8
Prev: #14
2.1
—
27,201 4.4%
P
S
649,924 $23,033,307 2026 Q2 13F Filing 2026-09-30 2026-11-16
ELVN
ENLIVEN THERAPE...
Healthcare 2.71% 3.03% #7
Prev: #7
1.6
—
-16,438 -4.7%
P
S
330,476 $15,149,020 2024 Q4 13F Filing 2026-09-30 2026-11-16
ALKS
ALKERMES PLC
Healthcare 2.41% 2.24% #8 5
Prev: #13
3.5
—
85,317 34.4%
P
S
333,332 $13,506,613 2024 Q3 13F Filing 2026-09-30 2026-11-16
ADPT
ADAPTIVE BIOTEC...
Healthcare 2.39% — #9
Prev: #—
4.5
—
463,551 —
NEW
463,551 $13,396,624 2025 Q4 13F Filing 2026-09-30 2026-11-16
DNTH
DIANTHUS THERAP...
Healthcare 2.37% 3.37% #10 4
Prev: #6
0.9
—
-50,075 -24.9%
P
S
150,776 $13,275,827 2024 Q1 13F Filing 2026-09-30 2026-11-16
SNSE
FAETH THERAPEUT...
Healthcare 2.15% — #11
Prev: #—
4.4
—
404,921 —
NEW
404,921 $12,042,351 2026 Q1 13F Filing 2026-09-30 2026-11-16
SYRE
SPYRE THERAPEUT...
Healthcare 2.10% 1.64% #12 12
Prev: #24
3.3
—
25,312 23.7%
P
S
132,238 $11,773,149 2023 Q4 13F Filing 2026-09-30 2026-11-16
IMTX
IMMATICS N.V
Healthcare 2.05% — #13
Prev: #—
4.3
—
1,308,193 —
NEW
1,308,193 $11,485,935 2023 Q4 13F Filing 2026-09-30 2026-11-16
GRAL
GRAIL INC
Healthcare 2.05% — #14
Prev: #—
4.3
—
81,924 —
NEW
81,924 $11,479,191 2026 Q3 13F Filing 2026-09-30 2026-11-16
PRAX
PRAXIS PRECISIO...
Healthcare 2.02% 2.15% #15
Prev: #15
1.3
—
1,477 4.0%
P
S
38,720 $11,276,426 2024 Q1 13F Filing 2026-09-30 2026-11-16
SRZN
SURROZEN INC
Healthcare 1.99% 2.37% #16 6
Prev: #10
0.8
—
-184,271 -30.6%
P
S
418,527 $11,117,745 2024 Q2 13F Filing 2026-09-30 2026-11-16
CCCC
C4 THERAPEUTICS...
Healthcare 1.96% 0.42% #17 43
Prev: #60
3.8
—
2,769,728 528.9%
P
S
3,293,376 $10,966,942 2026 Q1 13F Filing 2026-09-30 2026-11-16
ACRS
ACLARIS THERAPE...
Healthcare 1.93% — #18
Prev: #—
4.3
—
2,050,698 —
NEW
2,050,698 $10,786,671 2026 Q3 13F Filing 2026-09-30 2026-11-16
N/A
DAMORA THERAPEU...
Unknown 1.92% — #19
Prev: #—
4.3
—
506,067 —
NEW
506,067 $10,769,106 — 13F Filing 2026-09-30 2026-11-16
RVMD
REVOLUTION MEDI...
Healthcare 1.83% 5.16% #20 17
Prev: #3
0.7
—
-109,943 -68.7%
P
S
50,000 $10,263,000 2024 Q3 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
Healthcare 1.72% 1.11% #21 11
Prev: #32
3.7
—
70,157 92.8%
P
S
145,760 $9,607,042 2023 Q4 13F Filing 2026-09-30 2026-11-16
ONC
BEONE MEDICINES...
Healthcare 1.64% — #22
Prev: #—
4.2
—
25,051 —
NEW
25,051 $9,167,163 2026 Q3 13F Filing 2026-09-30 2026-11-16
XENE
XENON PHARMACEU...
Healthcare 1.48% 0.79% #23 17
Prev: #40
3.6
—
146,212 192.2%
P
S
222,287 $8,266,854 2024 Q4 13F Filing 2026-09-30 2026-11-16
JNJ
JOHNSON & JOHNS...
Healthcare 1.42% — #24
Prev: #—
4.1
—
30,000 —
NEW
30,000 $7,942,200 2023 Q4 13F Filing 2026-09-30 2026-11-16
TRVI
TREVI THERAPEUT...
Healthcare 1.41% — #25
Prev: #—
4.1
—
552,245 —
NEW
552,245 $7,908,148 2025 Q3 13F Filing 2026-09-30 2026-11-16
LLY
ELI LILLY & CO
Healthcare 1.36% — #26
Prev: #—
4.0
—
6,599 —
NEW
6,599 $7,635,571 2023 Q4 13F Filing 2026-09-30 2026-11-16
ARWR
ARROWHEAD PHARM...
Healthcare 1.29% 0.55% #27 25
Prev: #52
3.5
—
70,728 180.4%
P
S
109,926 $7,194,657 2023 Q4 13F Filing 2026-09-30 2026-11-16
CERS
CERUS CORP
Healthcare 1.26% — #28
Prev: #—
4.0
—
2,967,942 —
NEW
2,967,942 $7,063,702 2026 Q3 13F Filing 2026-09-30 2026-11-16
IMVT
IMMUNOVANT INC
Healthcare 1.22% 1.84% #29 9
Prev: #20
0.5
—
-75,193 -27.2%
P
S
201,334 $6,801,063 2023 Q4 13F Filing 2026-09-30 2026-11-16
JBIO
JADE BIOSCIENCE...
Healthcare 1.18% — #30
Prev: #—
4.0
—
471,718 —
NEW
471,718 $6,627,638 2026 Q1 13F Filing 2026-09-30 2026-11-16
GH
GUARDANT HEALTH...
Healthcare 1.07% — #31
Prev: #—
3.9
—
33,527 —
NEW
33,527 $5,979,876 2026 Q3 13F Filing 2026-09-30 2026-11-16
OABI
OMNIAB INC
Healthcare 1.07% — #32
Prev: #—
3.9
—
1,204,038 —
NEW
1,204,038 $5,972,028 2026 Q3 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
Healthcare 1.05% — #33
Prev: #—
3.9
—
184,173 —
NEW
184,173 $5,897,219 2026 Q3 13F Filing 2026-09-30 2026-11-16
BHVN
BIOHAVEN LTD
Healthcare 0.95% 2.73% #34 25
Prev: #9
0.4
—
-667,335 -62.7%
P
S
396,865 $5,298,148 2023 Q4 13F Filing 2026-09-30 2026-11-16
MLYS
MINERALYS THERA...
Healthcare 0.90% 2.80% #35 27
Prev: #8
0.4
—
-402,686 -66.8%
P
S
200,000 $5,026,000 2024 Q4 13F Filing 2026-09-30 2026-11-16
IDYA
IDEAYA BIOSCIEN...
Healthcare 0.85% — #36
Prev: #—
3.8
—
123,760 —
NEW
123,760 $4,754,859 2024 Q1 13F Filing 2026-09-30 2026-11-16
CELC
CELCUITY INC
Healthcare 0.82% 1.77% #37 16
Prev: #21
0.3
—
-40,323 -41.1%
P
S
57,880 $4,602,618 2025 Q3 13F Filing 2026-09-30 2026-11-16
GHRS
GH RESEARCH PLC
Healthcare 0.82% — #38
Prev: #—
3.8
—
195,143 —
NEW
195,143 $4,581,958 2025 Q2 13F Filing 2026-09-30 2026-11-16
EWTX
EDGEWISE THERAP...
Healthcare 0.81% — #39
Prev: #—
3.8
—
111,577 —
NEW
111,577 $4,530,026 2024 Q2 13F Filing 2026-09-30 2026-11-16
IFRX
INFLARX NV
Healthcare 0.80% 1.25% #40 14
Prev: #26
0.3
—
-743,022 -23.0%
P
S
2,485,233 $4,473,419 2025 Q1 13F Filing 2026-09-30 2026-11-16
IPSC
CENTURY THERAPE...
Healthcare 0.78% 0.91% #41 6
Prev: #35
2.3
—
417,680 19.5%
P
S
2,563,862 $4,384,204 2026 Q2 13F Filing 2026-09-30 2026-11-16
BDSX
BIODESIX INC
Healthcare 0.75% 0.27% #42 24
Prev: #66
3.3
—
71,548 102.2%
P
S
141,548 $4,222,377 2026 Q1 13F Filing 2026-09-30 2026-11-16
BNTX
BIONTECH SE
Healthcare 0.74% — #43
Prev: #—
3.8
—
42,200 —
NEW
42,200 $4,148,260 2024 Q4 13F Filing 2026-09-30 2026-11-16
SNY
SANOFI SA
Healthcare 0.74% — #44
Prev: #—
3.8
—
99,880 —
NEW
99,880 $4,118,052 2026 Q3 13F Filing 2026-09-30 2026-11-16
AURA
AURA BIOSCIENCE...
Healthcare 0.73% 0.87% #45 9
Prev: #36
0.8
—
-66,874 -9.4%
P
S
647,406 $4,065,710 2026 Q2 13F Filing 2026-09-30 2026-11-16
CGON
CG ONCOLOGY INC
Healthcare 0.69% 1.95% #46 28
Prev: #18
0.3
—
-104,558 -65.6%
P
S
54,791 $3,884,134 2024 Q1 13F Filing 2026-09-30 2026-11-16
NAMS
NEWAMSTERDAM PH...
Healthcare 0.69% 0.45% #47 10
Prev: #57
3.3
—
81,455 105.0%
P
S
159,044 $3,867,950 2024 Q1 13F Filing 2026-09-30 2026-11-16
KNSA
KINIKSA PHARMAC...
Healthcare 0.69% 2.30% #48 37
Prev: #11
0.3
—
-157,430 -75.2%
P
S
51,804 $3,865,096 2026 Q2 13F Filing 2026-09-30 2026-11-16
VRDN
VIRIDIAN THERAP...
Healthcare 0.69% — #49
Prev: #—
3.8
—
187,320 —
NEW
187,320 $3,856,919 2025 Q4 13F Filing 2026-09-30 2026-11-16
VOR
VOR BIOPHARMA I...
Healthcare 0.68% — #50
Prev: #—
3.8
—
200,836 —
NEW
200,836 $3,831,951 2026 Q3 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 130 holdings

Unlock Full STEMPOINT CAPITAL LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →